Empirical Studies on Strategic CSR increasing corporate values in a Pharmaceutical Company

处方药的特点是医生代表患者利用他们的专业知识来决定要购买的药物。这一决策过程不同于一般消费品的决策过程。基于医生、患者和制药公司之间的特定关系，我们进行了实证研究，以明确1)制药公司的企业社会责任(CSR)活动是否会导致处方药销量的增加，2)什么样的CSR活动可以增加制药公司的企业价值。作为对544名医生进行的假设性实证研究的结果，企业社会责任活动影响了他们在特定条件下选择处方药的决定。此外，“价值交付”活动，包括提供相关治疗领域的信息，向发展中国家提供自己的药物，以及提供奖学金，增加了公司价值。

Prescription drugs are characterized by the fact that physicians make decisions on drugs to be purchased, using their professional expertise on behalf of patients. This decision-making process is different from that of general consumer products. Based on the given relationship among physicians, patients, and pharmaceutical companies, we conducted empirical studies to clarify 1) whether pharmaceutical company's Corporate Social Responsibility (CSR) activities lead to increased sales of prescription drugs,2) what kind of CSR activities can increase corporate value in a pharmaceutical company. As a result of hypothetical empirical studies involving 544 physicians, CSR activities affected their decision of selecting prescription drugs under given conditions. Also, “value delivery” activity including providing information on related therapeutic area, supplying own drugs to developing countries, and providing scholarships increased the corporate value.